Description
GIBH-130 is a neuroinflammation inhibitor. GIBH-130 that significantly suppresses the IL-1β secretion by activated microglia. Suppresses the proinflammatory cytokine production in LPS-stimulated N9 microglial cells (IC₅₀ = 3.4 nM).
GIBH-130 is a neuroinflammation inhibitor. GIBH-130 that significantly suppresses the IL-1β secretion by activated microglia. Suppresses the proinflammatory cytokine production in LPS-stimulated N9 microglial cells (IC₅₀ = 3.4 nM).
Alternate Name/Synonyms: (4-methyl-6-phenylpyridazin-3-yl)-(4-pyrimidin-2-ylpiperazin-1-yl)methanone
Appearance: Crystalline solid
Formulation: N/A
CAS Number: 1252608-59-5
Structure Available?: Yes
Peptide sequence: N/A
Salt Form: No
Molecular Formula: C₂₀H₂₀N₆O
Molecular Weight: 360.42
Cell-Permeable?: Yes
Purity: ≥98% by HPLC
Solubilities: DMSO
Handling: Protect from air and light
Country of Origin: USA
Tag Line: A neuroinflammation inhibitor.
MDL Number: N/A
PubChem CID: 50938773
SMILES: CC1=CC(=NN=C1C(=O)N2CCN(CC2)C3=NC=CC=N3)C4=CC=CC=C4
InChi: InChI=1S/C20H20N6O/c1-15-14-17(16-6-3-2-4-7-16)23-24-18(15)19(27)25-10-12-26(13-11-25)20-21-8-5-9-22-20/h2-9,14H,10-13H2,1H3
InChi Key: ZTJHTEHADIHZJS-UHFFFAOYSA-N
Additional Information
Storage Condition: |
-20°C |
Shipping Condition: |
Gel Pack |
Shelf Life: |
36 months |